<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>To elucidate the mechanism whereby <z:chebi fb="0" ids="50858">corticosteroids</z:chebi> decrease the serum <z:chebi fb="0" ids="16990">bilirubin</z:chebi> concentration, changes in <z:chebi fb="0" ids="16990">bilirubin</z:chebi> metabolism were studied in patients with <z:e sem="disease" ids="C0017551" disease_type="Disease or Syndrome" abbrv="">Gilbert's syndrome</z:e> using a <z:chebi fb="0" ids="16990">bilirubin</z:chebi> load test and/or <z:chebi fb="5" ids="15940">nicotinic acid</z:chebi> test before and after <z:chebi fb="0" ids="50858">corticosteroid</z:chebi> treatment </plain></SENT>
<SENT sid="1" pm="."><plain>Steroid administration increased hepatic clearance and uptake of <z:chebi fb="0" ids="16990">bilirubin</z:chebi>; the transfer rate for biliary excretion was unaffected </plain></SENT>
<SENT sid="2" pm="."><plain>These results suggest that the main effect was enhancement of hepatic uptake or storage of <z:chebi fb="0" ids="16990">bilirubin</z:chebi>, which may be an important mechanism whereby <z:chebi fb="0" ids="50858">corticosteroids</z:chebi> reduce serum <z:chebi fb="0" ids="16990">bilirubin</z:chebi> concentrations in various <z:e sem="disease" ids="C0023895" disease_type="Disease or Syndrome" abbrv="">liver disorders</z:e> </plain></SENT>
</text></document>